End-of-day quote
Other stock markets
|
||
- USD | - |
Mar. 26 | Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
Mar. 26 | NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Eyecare & Wound Care
75.9
%
| 10 | 71.1 % | 11 | 75.9 % | +9.13% |
Skincare
24.1
%
| 4 | 28.9 % | 4 | 24.1 % | -14.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 14 | 100.0 % | 15 | 100.0 % | +2.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 19-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 02-04-30 |
Yen You Zheng
BRD | Director/Board Member | 67 | 19-09-10 |
Bob Wu
BRD | Director/Board Member | 49 | 16-01-25 |
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Julie Garlikov
BRD | Director/Board Member | 53 | 22-01-26 |
Swan Sit
BRD | Director/Board Member | 47 | 19-12-16 |
Sean Zheng
BRD | Director/Board Member | 54 | 22-01-26 |
Company contact information
NovaBay Pharmaceuticals, Inc.
2000 Powell Street Suite 1150
94608-1866, Emeryville
+510 899 8800
http://www.novabay.comSector
Sales per Business
- Stock Market
- Equities
- NBY Stock
- Stock
- Company NovaBay Pharmaceuticals, Inc.